Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study

References

• Chock VY, Punn R, Oza A, et al. Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosus. Pediatr Res. 2014;75(4):570–575.
   PubMed Web of Science ®Google Scholar
• Gudmundsdottir A, Johansson S, Håkansson S, et al. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants. Neonatology. 2015;107(2):87–92.
   PubMed Web of Science ®Google Scholar
• Sellmer A, Bjerre JV, Schmidt MR, et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed. 2013;98(6):F505–F510.
   PubMed Web of Science ®Google Scholar
• Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30(4):241–252.
   PubMed Web of Science ®Google Scholar
• Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):102–107.
   PubMed Web of Science ®Google Scholar
• Benitz WE. Patent ductus arteriosus: to treat or not to treat? Arch Dis Child Fetal Neonatal Ed. 2012;97(2):F80–F82.
   PubMed Web of Science ®Google Scholar
• Sallmon H, Koehne P, Hansmann G. Recent advances in the treatment of preterm newborn infants with patent ductus arteriosus. Clin Perinatol. 2016;43(1):113–129.
   PubMed Web of Science ®Google Scholar
• Benitz WE. Committee on Fetus and Newborn. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137(1):10.1542.
   Web of Science ®Google Scholar
• Heuchan AM, Clyman RI. Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed. 2014;99(5):F431–F436.
   PubMed Web of Science ®Google Scholar
• Irmesi R, Marcialis MA, Anker JVD, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) in the management of patent ductus arteriosus (PDA) in preterm infants and variations in attitude in clinical practice: A flight around the world. Curr Med Chem. 2014;21(27):3132–3152.
   PubMed Web of Science ®Google Scholar
• Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994;93(4):543–550.
   PubMed Web of Science ®Google Scholar
• Naik-Mathuria B, Chang S, Fitch ME, et al. Patent ductus arteriosus ligation in neonates: preoperative predictors of poor postoperative outcomes. J Pediatr Surg. 2008;43(6):1100–1105.
   PubMed Web of Science ®Google Scholar
• Weisz DE, More K, McNamara PJ, et al. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133(4):e1024–e1046.
   PubMed Web of Science ®Google Scholar
• Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health. 1994;30(5):406–411.
   PubMed Web of Science ®Google Scholar
• Jain A, Shah PS. Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates. JAMA Pediatr. 2015;169(9):863–872.
   PubMed Web of Science ®Google Scholar
• Skinner J, Skinner J, Alverson D, et al. Echocardiography for the neonatologist. Vol. XI. London: Churchill Livingstone; 2000. p. 243.
   Google Scholar
• Zonnenberg I, de Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr. 2012;101(3):247–251.
   PubMed Web of Science ®Google Scholar
• Sankilampi U, Hannila ML, Saari A, et al. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med. 2013;45(5–6):446–454.
   PubMed Web of Science ®Google Scholar
• International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991–999.
   PubMed Web of Science ®Google Scholar
• Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
   PubMed Web of Science ®Google Scholar
• Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529–534.
   PubMed Web of Science ®Google Scholar
• Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114(5):1305–1311.
   PubMed Web of Science ®Google Scholar
• Clyman R, Cassady G, Kirklin JK, et al. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr. 2009;154(6):873–876.
   PubMed Web of Science ®Google Scholar
• Sadeck LS, Leone CR, Procianoy RS, et al. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus. J Pediatr (Rio J). 2014;90(6):616–623.
   PubMedGoogle Scholar
• Madan JC, Kendrick D, Hagadorn JI, et al. Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 2009;123(2):674–681.
   PubMed Web of Science ®Google Scholar
• Sung SI, Chang YS, Chun JY, et al. Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J Pediatr. 2016;177:66–71.e1.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Roberts RS, Fanaroff A, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the trial of indomethacin prophylaxis in preterms (TIPP). J Pediatr. 2006;148(6):730–734.
   PubMed Web of Science ®Google Scholar
• Terek D, Yalaz M, Ulger Z, et al. Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants. J Res Med Sci. 2014;19(11):1074–1079.
   PubMed Web of Science ®Google Scholar
• Lee HC, Durand DJ, Danielsen B, et al. Hospital variation in medical and surgical treatment of patent ductus arteriosus. Am J Perinatol. 2015;32(4):379–386.
   PubMed Web of Science ®Google Scholar
• Fajardo MF, Claure N, Swaminathan S, et al. Effect of positive end-expiratory pressure on ductal shunting and systemic blood flow in preterm infants with patent ductus arteriosus. Neonatology. 2014;105(1):9–13.
   PubMed Web of Science ®Google Scholar
• Kallankari H, Kaukola T, Ojaniemi M, et al. Chemokine CCL18 predicts intraventricular hemorrhage in very preterm infants. Ann Med. 2010;42(6):416–425.
   PubMed Web of Science ®Google Scholar
• Szpecht D, Szymankiewicz M, Nowak I, et al. Intraventricular hemorrhage in neonates born before 32 weeks of gestation-retrospective analysis of risk factors. Childs Nerv Syst. 2016;32(8):1399–1404.
   PubMed Web of Science ®Google Scholar
• Soleymani S, Khoo MC, Noori S, et al. Modeling of neonatal hemodynamics during PDA closure. Conf Proc IEEE Eng Med Biol Soc Conference Proc IEEE Energy Med Biol Soc. 2015;2015:1886–1889.
   PubMedGoogle Scholar
• Jhaveri N, Moon-Grady A, Clyman RI. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr. 2010;157(3):381–7, 387.e1.
   PubMed Web of Science ®Google Scholar